Relevant disclosures attached
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare reported strong FY2025-26 results with revenue from operations growing 17.3% to Rs 912,784 lakhs from Rs 778,275 lakhs in FY25. Net profit jumped 31.5% to Rs 106,419 lakhs from Rs 80,938 lakhs, while EBITDA rose 29% to Rs 213,564 lakhs. EPS improved to Rs 13.80 from Rs 10.26. The Board recommended a final dividend of Rs 1 per equity share. Statutory auditors B S R & Co. LLP issued an unmodified (clean) opinion. However, the auditors included an Emphasis of Matter noting ongoing SFIO investigation regarding alleged improper transactions from periods prior to 2018 and a Supreme Court order related to RHT Health Trust transactions - though the audit opinion was not modified. The company also appointed M/s Jitender, Navneet & Co. as Cost Auditor for FY2026-27.
Strong financial performance with clean audit opinion and 31.5% PAT growth is positive for shareholders. The Emphasis of Matter on past SFIO investigation and RHT Health Trust matters carries some residual regulatory risk but did not affect the auditors' opinion.